Form 4 Tracker
RHYTHM PHARMACEUTICALS, INC.
RYTM

35 insider filings · Latest: Jun 23, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 28, 2025Oct 28 8:17 PMJOSEPH SHULMAN
Proposed Sale
2,815$111.55$314.0K

View →

Oct 16, 2025Oct 16 8:20 PMJOSEPH SHULMAN
Proposed Sale
14,437$109.35$1.6M

View →

Sep 2, 2025Sep 2 8:41 PMJOSEPH SHULMAN
Proposed Sale
16,781$103.15$1.7M

View →

Aug 21, 2025Aug 21 8:45 PMJOSEPH SHULMAN
Proposed Sale
4,188$98.70$413.4K

View →

Aug 12, 2025Aug 12 8:28 PMHUNTER SMITH
Proposed Sale
28,088$94.31$2.6M

View →

Aug 12, 2025Aug 12 8:26 PMCHRISTOPHER PAUL GERMAN
Proposed Sale
1,500$94.31$141.5K

View →

Aug 11, 2025Aug 11 8:22 PMJOSEPH SHULMAN
Proposed Sale
3,984$91.98$366.4K

View →

Jul 9, 2025Jul 9 8:17 PMCHRISTOPHER PAUL GERMAN
Proposed Sale
3,817$65.14$248.6K

View →

Jul 9, 2025Jul 9 8:17 PMPAMELA CRAMER
Proposed Sale
15,572$65.14$1.0M

View →

Jul 9, 2025Jul 9 8:16 PMHUNTER SMITH
Proposed Sale
42,120$65.14$2.7M

View →

Jul 9, 2025Jul 9 8:16 PMJOSEPH J SHULMAN
Proposed Sale
7,969$65.14$519.1K

View →

Jun 10, 2025Jun 10 8:21 PMCHRISTOPHER PAUL GERMAN
Proposed Sale
2,069$66.72$138.0K

View →

Jun 6, 2025Jun 6 8:25 PMPAMELA CRAMER
Proposed Sale
7,031$66.18$465.3K

View →

Jun 3, 2025Jun 3 8:27 PMDAVID W MCGIRR
Proposed Sale
65,431$63.66$4.2M

View →

Jun 3, 2025Jun 3 8:27 PMDAVID MEEKER
Proposed Sale
43,621$63.66$2.8M

View →

May 30, 2025May 30 8:35 PMHUNTER SMITH
Proposed Sale
23,400$61.88$1.4M

View →

Apr 29, 2025Apr 29 8:21 PMYANN MAZZABRAUD
Proposed Sale
6,745$64.41$434.4K

View →

Apr 29, 2025Apr 29 8:20 PMPAMELA CRAMER
Proposed Sale
7,031$64.41$452.9K

View →

Apr 8, 2025Apr 8 8:18 PMPAMELA CRAMER
Proposed Sale
20,760$54.96$1.1M

View →

Apr 8, 2025Apr 8 8:16 PMYANN MAZZABRAUD
Proposed Sale
17,750$54.96$975.5K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 11, 2026Feb 13 10:53 PMJoseph ShulmanChief Technical Officer
Grant/Award
37,500$98.4722,500(D)

View →

Feb 11, 2026Feb 13 10:52 PMDavid P MeekerDirector, President and CEO
Grant/Award
179,750$98.47107,850(D)

View →

Feb 11, 2026Feb 13 10:50 PMYann MazabraudEVP, Head of International
Grant/Award
23,35023,350(D)

View →

Feb 11, 2026Feb 13 10:49 PMJennifer Kayden LeeEVP, Head of North America
Grant/Award
54,150$98.4732,500(D)

View →

Feb 11, 2026Feb 13 10:48 PMChristopher Paul GermanCorporate Controller & CAO
Grant/Award
5,2155,215(D)

View →

Feb 11, 2026Feb 13 10:47 PMAlastair GarfieldChief Scientific Officer
Grant/Award
41,650$98.4725,000(D)

View →

Feb 11, 2026Feb 13 10:45 PMPamela J. CramerChief Human Resources Officer
Grant/Award
29,150$98.4717,500(D)

View →

Feb 11, 2026Feb 13 1:56 AMHunter C SmithChief Financial Officer
Grant/Award
62,500$98.4737,500(D)

View →

Feb 1, 2026Feb 3 9:38 PMYann MazabraudEVP, Head of International
Option Exercise
5,50011,000(D)

View →

Feb 1, 2026Feb 3 9:36 PMHunter C SmithChief Financial Officer
Option Exercise
26,00031,237(D)

View →

Feb 1, 2026Feb 3 9:35 PMJoseph ShulmanChief Technical Officer
Option Exercise
16,96818,750(D)

View →

Feb 1, 2026Feb 3 9:34 PMDavid P MeekerDirector, President and CEO
Option Exercise
68,713100,012(D)

View →

Feb 1, 2026Feb 3 9:33 PMJennifer Kayden LeeEVP, Head of North America
Option Exercise
22,61227,487(D)

View →

Feb 1, 2026Feb 3 9:32 PMChristopher Paul GermanCorporate Controller & CAO
Option Exercise
3,6135,418(D)

View →

Feb 1, 2026Feb 3 9:31 PMAlastair GarfieldChief Scientific Officer
Option Exercise
6,66319,987(D)

View →

Feb 1, 2026Feb 3 9:30 PMPamela J. CramerChief Human Resources Officer
Option Exercise
13,29315,000(D)

View →

← Previous

Page 2 of 2